Asaka, Japan

Hitoshi Shirakawa

This inventor holds 1 USPTO granted patent. Top assignee: Kaneka Corporation. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitoshi Shirakawa. Retrieved from https://idiyas.com/inventor/hitoshi-shirakawa-ohqtpec9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hitoshi Shirakawa: Innovator in Diagnostic Drugs for Autoimmune Diseases

Introduction

Hitoshi Shirakawa is a prominent inventor based in Asaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the development of diagnostic drugs for autoimmune diseases. His innovative work has the potential to improve the lives of many patients suffering from these conditions.

Latest Patents

Hitoshi Shirakawa holds 1 patent related to diagnostic drugs for autoimmune diseases. This patent includes a diagnostic drug and a diagnostic kit that utilizes at least one polypeptide selected from the HMG-1 family and one from the HMG-2 family. The invention also encompasses a method for detecting antibodies in autoimmune disease patients, which is crucial for accurate diagnosis and treatment.

Career Highlights

Shirakawa is currently associated with Kaneka Corporation, where he continues to work on innovative solutions in the medical field. His expertise and dedication to research have positioned him as a key figure in the development of diagnostic technologies.

Collaborations

Some of his notable coworkers include Masao Tanaka and Hiroko Uesugi. Their collaborative efforts contribute to the advancement of research and development in the field of diagnostics.

Conclusion

Hitoshi Shirakawa's work in developing diagnostic drugs for autoimmune diseases showcases his commitment to innovation and improving patient care. His contributions are vital in the ongoing quest for effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…